Literature DB >> 2819747

Alterations in beta-adrenoceptor number and catecholamine content of chick atria after reversible sympathetic denervation with 6-hydroxydopamine.

K Williams, P G Strange, T Bennett.   

Abstract

1. The characteristics of [3H]-dihydroalprenolol (DHA) binding were determined in atria from untreated chicks. [3H]-DHA binding to atrium homogenates was rapid (k1 = 8.52 X 10(8) l mol-1 min-1), reversible (k-1 = 0.47 min-1), saturable, and of high affinity (KD = 0.6-1.0 nmol/l). Isoprenaline competed for specific [3H]-DHA binding in a stereoselective manner; IC50 values (mumol/l) were: (-)isoprenaline 0.12, (+)isoprenaline 4.7. 2. The number of [3H]-DHA binding sites and catecholamine content of left and right atria were examined after injection of chicks with a single dose of 6-hydroxydopamine hydrobromide (100 mg/kg). There were transient increases in the number of [3H]-DHA binding sites in both the left and the right atrium after 6-OHDA treatment. These increases were quicker in onset and in offset in the right atrium than in the left atrium. [3H]-DHA binding was significantly increased in the left atrium at 5 and 7 days, and in the right atrium at 3 and 5 days after 6-OHDA injection. 3. Saturation binding isotherms indicated that the increase in [3H]-DHA binding was due to an increase in beta-adrenoceptor number with no change in affinity for [3H]-DHA. 4. Twenty four hours after 6-OHDA treatment there was a significant (80%) decrease in noradrenaline content of left and of right atria. 5. The decrease in noradrenaline content was reversible, noradrenaline levels returning to 55% of control in left atrium and to 71% of control in right atrium by 21 days after 6-OHDA treatment. These changes are consistent with reversible sympathetic denervation of the atria.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2819747     DOI: 10.1007/BF00177752

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  20 in total

1.  A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines.

Authors:  A H ANTON; D F SAYRE
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

2.  Elevated beta-adrenergic receptor number after chronic propranolol treatment.

Authors:  G Glaubiger; R J Lefkowitz
Journal:  Biochem Biophys Res Commun       Date:  1977-09-23       Impact factor: 3.575

3.  Evidence for noradrenaline and adrenaline as sympathetic transmitters in the chicken.

Authors:  V P DeSantis; W Långsfeld; R Lindmar; K Loffelholz
Journal:  Br J Pharmacol       Date:  1975-11       Impact factor: 8.739

4.  Regeneration of the noradrenergic innervation of the cardiovascular system of the chick following treatment with 6-hydroxydopamine.

Authors:  T Bennett; T Malmfors
Journal:  J Physiol       Date:  1974-10       Impact factor: 5.182

5.  Effect of reserpine pretreatment on mechanical responsiveness and [125I]Iodohydroxybenzylpindolol binding sites in the guinea-pig right atrium.

Authors:  T J Torphy; D P Westfall; W W Fleming
Journal:  J Pharmacol Exp Ther       Date:  1982-11       Impact factor: 4.030

6.  Mechanisms of supersensitivity and subsensitivity to sympathomimetic amines.

Authors:  U Trendelenburg
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

7.  beta-Adrenoceptor ligand binding and supersensitivity to isoprenaline of ventricular muscle after chronic reserpine pretreatment.

Authors:  M H Hawthorn; K J Broadley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-09       Impact factor: 3.000

8.  Hypersensitivity of cardiac beta-adrenergic receptors after neonatal treatment of rats with 6-hydroxydopa.

Authors:  Y Nomura; H Kajiyama; T Segawa
Journal:  Eur J Pharmacol       Date:  1980-08-29       Impact factor: 4.432

9.  Changes in the density of beta adrenergic receptors in rat lymphocytes, heart and lung after chronic treatment with propranolol.

Authors:  R D Aarons; P B Molinoff
Journal:  J Pharmacol Exp Ther       Date:  1982-05       Impact factor: 4.030

10.  Use of [3H]spiperone for labelling dopaminergic and serotonergic receptors in bovine caudate nucleus.

Authors:  R M Withy; R J Mayer; P G Strange
Journal:  J Neurochem       Date:  1981-11       Impact factor: 5.372

View more
  1 in total

1.  Adverse effects on rat cardiac function ex vivo after repeated administration of the benzodiazepine partial inverse agonist, FG7142.

Authors:  S C Stanford; D Gettins; H J Little
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.